"Leica" Novocastra Liquid Mouse Monoclonal Antibody Epidermal Growth Factor Receptor (Non-Sterile)
Taiwan·Risk Class 1·MD·LEICA BIOSYSTEMS NEWCASTLE LTD.·Registered Jul 18, 2018 – Jul 18, 2028Active- Analysis ID
- 4fa2dc5f496bc24711a16cbc9eebce6c
- License Form
- Ministry of Health Medical Device Import No. 019324
- Customs Code
- DHA09401932401
- Manufacturer
- LEICA BIOSYSTEMS NEWCASTLE LTD.
- Manufacturer Country
- United Kingdom
- Authorized Representative
- BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.)
- Intended Use
- Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B1860 Immunopathological histochemical reagents and kits
- Import Information
- Imported from abroad
- Registration Date
- Jul 18, 2018
- Expiry Date
- Jul 18, 2028
Access comprehensive regulatory information for "Leica" Novocastra Liquid Mouse Monoclonal Antibody Epidermal Growth Factor Receptor (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 4fa2dc5f496bc24711a16cbc9eebce6c and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.